Histology and Cytology Market By Type of Examination (Cytology and Histology) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

The histology and cytology market is set to grow from US$ 8,928.1 Mn in 2017 to 27,949.9 Mn by 2026 at a compounded annual growth rate (CAGR) of 13.6% during the forecast period from 2018 to 2026. As per the research citings provided by World Health Organization (WHO) the global burden of cancer is  approximately 18.1 million new cases and with 9.6 million deaths in 2018. The major factors responsible for the occurrence of chronic disease are increasing consumption of tobacco, alcohol, junk food, sedentary lifestyle and stress. Researchers are of the view that in the light of in the era of modern technology, utilization of sophisticated technology pertaining to histology and cytology examinations will help in promoting early diagnosis and curtailing morbidity associated with chronic ailments. Rising public health awareness will further bolster the histology and cytology market growth during the forecast period from 2018 to 2026. 

Market Synopsis

Histology And Cytology Market 

Get a sample copy for more information

"Increasing demand for cell screening and inherent features such as low cost, high sensitivity and adequate specificity drive the cytology examination market growth"

Cytology examination are dominating the type of examination segment for histology and cytology market. The growth factors creating a positive impact in the cytology examination market growth are increasing demand for cell screening in breast and cervical cancer patients. Inherent features such as low cost, high sensitivity and adequate specificity associated with cytology examination procedure further fortify its market growth. Histology examination procedures will be growing at a rapid pace on account of technological advancement in tissue diagnostic kits and strategic collaboration among major players for further development and commercialization of histology examination procedures in diagnosis of chronic ailments.

Histology And Cytology Market

Get a sample copy for more information

"Significant rise in cancer diagnosis and increasing public health awareness drive the market growth in North America"

North America currently holds 35% market share and is the leading regional market for histology and cytology market. The major factors controlling its market growth are significant rise in cancer diagnosis and increasing public health awareness. As per the statistics provided by Center for Disease Control and Prevention (CDC) in 2017, the number of adults been diagnosed with cancer were 23.2 million which represents 9.4% of the total population. Existence of key players such as Abbott Laboratories, Inc., Hologic, Inc., Thermo Fisher Scientific, Inc. etc. provide a positive impetus to the histology and cytology market growth in North America region. Europe holds 30% market share on account of rising prevalence of cancer and supportive environment provided by European Medical Agency (EMA) for histology and cytology diagnostic procedures. Asia Pacific is accountable for 16% share and is keen to register outstanding growth owing to rampant growth in healthcare infrastructure development and adoption to sophisticated diagnostic technology pertaining to cytology and histology studies.

Histology And Cytology Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by type of examination and by geography.

Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Billion

 By Type of Examination (2016–2026; US$ Mn)
 • Cytology
   o Cervical Cancer
   o Breast Cancer
   o Other Cancers
 • Histology

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of APAC)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of Middle East and Africa)

Biotechnology companies specializing in histology and cytology market are Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F.Hoffman-La Roche Ltd., Trivitron Healthcare, Hologic, Inc., Koninklijke Philips N.V. and Life Technologies Corporation.

Key questions answered in this report

  • Which biotechnology companies are engaged in the development of histology and cytology examination technology?
  • What is the global prevalence rate of life threatening chronic ailments?
  • Which strategic collaboration and mergers among major players will promote the histology and cytology market growth?
  • Which factors are responsible for the disease manifestation of cancer?
  • Why is cytology examination procedure more popular in comparison to histology examination procedure?
  • Why is North America and Europe responsible for the major market share in regional segment for histology and cytology market?
Choose License Type
Published Date:  Apr 2019
Category:  Biotechnology
Report ID:   59673
Report Format:   PDF
Pages:   120
Rating:    4.2 (49)
Connect With Us
24/7 Research Support